Tissue-specific and reversible RNA interference in transgenic mice
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Genetically engineered mice provide powerful tools for understanding mammalian gene function. These models traditionally rely on gene overexpression from transgenes or targeted, irreversible gene mutation. By adapting the tetracycline (tet)-responsive system previously used for gene overexpression, we have developed a simple transgenic system to reversibly control endogenous gene expression using RNA interference (RNAi) in mice. Transgenic mice harboring a tet-responsive RNA polymerase II promoter driving a microRNA-based short hairpin RNA targeting the tumor suppressor Trp53 reversibly express short hairpin RNA when crossed with existing mouse strains expressing general or tissue-specific 'tet-on' or 'tet-off' transactivators. Reversible Trp53 knockdown can be achieved in several tissues, and restoring Trp53 expression in lymphomas whose development is promoted by Trp53 knockdown leads to tumor regression. By leaving the target gene unaltered, this approach permits tissue-specific, reversible regulation of endogenous gene expression in vivo, with potential broad application in basic biology and drug target validation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the outcome of endogenous p53 reactivation can be senescence and/or cell death depending on the tumour type 35,141,142”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“Tet-regulated gene overexpression systems were initially developed for use in cultured cell”
Identification of tissue-specific microRNAs from mouse
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 3,355 · cited 1×
“siRNA production was inhibited by addition of doxycycline to the drinking water, with no effect on the levels of the endogenous liver-specific microRNA miR-122 (ref”
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Self-citationSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“Our results are generally consistent with recent studies from our group and other group”
Self-citationRestoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“Our results are generally consistent with recent studies from our group and other group”
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677 · cited 1×
“In developing this approach, we were concerned that the levels of tet transactivator produced in existing mouse strains would be insufficient to drive functional shRNA expression or, alternatively, that overexpression of the exogenous microRNA would saturate the RNAi machinery leading to off-target effects as has rece…”
Genetic transformation of mouse embryos by microinjection of purified DNA.
Gordon, J. W., Scangos, G. A., Plotkin, D. J., Barbosa, J. A., & Ruddle, F. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7380 · Cited by 1,435
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Conditional control of gene expression in the mouse
Lewandoski, M. (2001) · Nature Reviews Genetics · doi:10.1038/35093537 · Cited by 781
Cited by
Items 101–174 of 174
Riboregulators in kidney development and function
Karolina, D. S., Wintour, E. M., Bertram, J. F., & Jeyaseelan, K. (2010) · Biochimie · doi:10.1016/j.biochi.2009.12.008 · Cited by 15
Targeting genes in living mammals by RNA interference
Podolská, K., & Svoboda, P. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr013 · Cited by 15
“Inducible RNAi has been successfully generated using tetracycline or ecdysone-induced shRNA expression in mammalian cells [30, 45, 46].”
BackgroundMethodInfluentialInhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and Progression
Vail, M. E., Farnsworth, R. H., Hii, L. L., Allen, S. M., Arora, S., Anderson, R. L., Dickins, R. A., Orimo, A., Wu, S. Z., Swarbrick, A., et al. (2023) · Cancers · doi:10.3390/cancers15184646 · Cited by 14
Self-citationNaderi, E. H., Ugland, H. K., Diep, P.-P., Josefsen, D., Ruud, E., Naderi, S., & Blomhoff, H. K. (2013) · Blood · doi:10.1182/blood-2012-08-452698 · Cited by 15
Lim, H., van den Brandt, J., Faßnacht, M., Allolio, B., Herold, M. J., & Reichardt, H. M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0417 · Cited by 15
“Despite successful transgene integration, DsRed expression was quite variable in different cell types, consistent with the known expression pattern of the cytomegalovirus promoter (15).”
BackgroundInducible and reversible regulation of endogenous gene in mouse
Sun, R., Zhao, K., Shen, R., Cai, L., Yang, X., Kuang, Y., Mao, J., Huang, F., Wang, Z., & Fei, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks738 · Cited by 14
“Similar to conventional gene targeting, the conditional gene knockout irreversibly disrupts the target gene expression, and transient inhibition of endogenous genes in a specific developmental stage is impossible (4,5).”
BackgroundTetracycline-regulated mouse models of cancer.
Yeh, E. S., Vernon-Grey, A., Martin, H., & Chodosh, L. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top069823 · Cited by 12
“delivery allows for the suppression of endogenous gene expression, providing a more tightly controlled experimental system for loss of function studies in comparison to traditional knockout models (Dickins et al. 2007; Dow et al. 2012).”
BackgroundResultInfluentialIn vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
Bowman, R. L., Dunbar, A. J., Mishra, T., Xiao, W., Waarts, M. R., Fernández-Maestre, I., Eisman, S. E., Cai, L., Mowla, S., Shah, N., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.10.009 · Cited by 16
Applications of RNA interference-based gene silencing in animal agriculture
Long, C. R., Tessanne, K. J., & Golding, M. C. (2009) · Reproduction Fertility and Development · doi:10.1071/rd09211 · Cited by 16
Modeling the Study of DNA Damage Responses in Mice
Specks, J., Nieto-Soler, M., Lopez-Contreras, A. J., & Fernández-Capetillo, Ó. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_21 · Cited by 14
“…1996, Ludwig et al., 1997, Allemand et al., 1999, Garcia-Cao et al., 2002, MacPherson et al., 2004, Sluss et al., 2004, Johnson and Attardi, 2006, Dickins et al., 2007) Parp1 Not known KO, KI (Pieper et al., 1999) Pms2 Hereditary nonpolyposis colorectal cancer KO (Baker et al., 1995) Ptip…”
BackgroundReversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference
Zaiss, A. K., Zuber, J. A., Chu, C., Machado, H. B., Jiao, J., Catapang, A. B., Ishikawa, T., Gil, J. S., Lowe, S. W., & Herschman, H. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101263 · Cited by 13
“Both a ‘tet-off’ system, in which the tet-transactivator (tTA) protein activates the TRE promoter but is inhibited by the administration of DOX and a ‘tet-on’ system, in which the reverse tettransactivator (rtTA) is latent until activated by DOX, are in common usage for reversible regulation of gene expression [18].”
BackgroundSelf-citationWang, Y., Hu, H., Pang, H., Zhou, X., Yu, L., Wang, L., Liu, C., Guo, K., Zhao, C., Liu, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030560 · Cited by 12
DNA-binding of the Tet-transactivator curtails antigen-induced lymphocyte activation in mice
Ottina, E., Peperzak, V., Schoeler, K., Carrington, E. M., Sgonc, R., Pellegrini, M., Preston, S., Herold, M. J., Strasser, A., & Villunger, A. (2017) · Nature Communications · doi:10.1038/s41467-017-01022-4 · Cited by 12
Cheng, X., Huo, Y., Fan, Y., Xiao, C., Ouyang, X., Liang, L., Lin, Y., Wu, J., Ren, J., & Guleng, B. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15332 · Cited by 11
Matthes, S., Mosienko, V., Popova, E., Rivalan, M., Bäder, M., & Alenina, N. V. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00635 · Cited by 12
Nakagawa, T., & Hoogenraad, C. C. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-974-1_8 · Cited by 11
Cell- and region-specific miR30-based gene knock-down with temporal control in the rat brain
Liu, B., Xu, H., Paton, J. F. R., & Kasparov, S. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-93 · Cited by 15
“Secondly, the expression of miR-shRNAs and protein mRNAs in a monocistronic transcript could lead to both effective processing of the miR-shRNAs and translation of protein from the mRNA [15,35,36].”
BackgroundAlbers, C., Illert, A. L., Miething, C., Leischner, H., Thiede, M., Peschel, C., & Duyster, J. (2011) · Blood · doi:10.1182/blood-2010-10-309583 · Cited by 12
Matsushita, N., Matsushita, S., Hirakawa, S., & Higashiyama, S. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.120917 · Cited by 18
Generation of an inducible mouse model to reversibly silence Stat3
Alorro, M., Pierce, T. P., Eissmann, M. F., Dijkstra, C., Dickins, R. A., Ernst, M., Büchert, M., & Masson, F. (2017) · genesis · doi:10.1002/dvg.23023 · Cited by 11
“PCR amplification of the 97mer shRNA sequence was performed from 10ng of oligo template using Phusion® Hot Start Polymerase (Finnzymes) as previously described (Dickins et al., 2007).”
MethodSelf-citationTransgenic, inducible RNAi in megakaryocytes and platelets in mice
Takiguchi, M., James, C., Josefsson, E. C., Carmichael, C., Premsrirut, P. K., Lowe, S. W., Hamilton, J. R., Huang, D. C. S., Kile, B. T., & Dickins, R. A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04077.x · Cited by 10
“We have recently shown that microRNA-based shRNAs driven from the TRE promoter can inhibit the expression of endogenous genes in transgenic mice [6].”
BackgroundSelf-citationHagen, J., Scheerlinck, J. Y., Young, N. D., Gasser, R. B., & Kalinna, B. H. (2015) · Advances in Parasitology/Advances in parasitology · doi:10.1016/bs.apar.2015.02.002 · Cited by 10
Ohte, N., Miyoshi, I., Sane, D. C., & Little, W. C. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0523 · Cited by 9
Shortcomings of short hairpin RNA-based transgenic RNA interference in mouse oocytes
Sarnová, L., Malík, R., Sedláček, R., & Svoboda, P. (2010) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-9-8 · Cited by 8
“The first shRNA systems were driven by pol III (reviewed in [13]). Pol II systems appeared later [ 14-17 ]”
BackgroundPreclinical tumor mouse models for studying esophageal cancer
Mahmoudian, R. A., Farshchian, M., Golyan, F. F., Mahmoudian, P., Alasti, A., Moghimi, V., Maftooh, M., Khazaei, M., Hassanian, S. M., Ferns, G. A., et al. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104068 · Cited by 9
Multipurpose modular lentiviral vectors for RNA interference and transgene expression
Kesireddy, V., van der Ven, P. F. M., & Fürst, D. O. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9840-8 · Cited by 8
Transgenic RNAi Applications in the Mouse
Seibler, J., & Schwenk, F. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)77019-1 · Cited by 7
Dufourny, L., Migaud, M., Thiéry, J., & Malpaux, B. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.12.018 · Cited by 10
Heitz, F. D., Johansson, T., Baumgärtel, K., Gecaj, R. M., Pelczar, P., & Mansuy, I. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00062 · Cited by 9
“…for gene silencing have been reported in the literature (Rubinson et al., 2003; Tiscornia et al., 2003; Coumoul et al., 2005; Szulc et al., 2006; Dickins et al., 2007; Delic et al., 2008; Seidler et al., 2008) but are often difficult to use due to their limitations such as insufficient temporal…”
BackgroundGenetic Mouse Models of Cancer
Winslow, M. M., & Jacks, T. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00009-3 · Cited by 7
Generation of Transgenic Drosophila Expressing shRNAs in the miR-1 Backbone
Chang, K., Marran, K., Valentine, A., & Hannon, G. J. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot080762 · Cited by 10
Self-citationRNA interference screening to detect targetable molecules in hematopoietic stem cells
Karlsson, C., Rak, J. M., & Larsson, J. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000053 · Cited by 6
Getting back on track: exploiting canalization to uncover the mechanisms of developmental robustness
Wong, M., & Gilmour, D. T. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.04.001 · Cited by 7
Murphy, K. C., & Ruscetti, M. A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041348 · Cited by 7
Towards the Molecular Mechanisms of Transgenerational Epigenetic Inheritance
Kaundal, R. K., Yang, Y., Nottoli, T., & Chi, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405944-3.00008-8 · Cited by 6
Moreno-Maldonado, R., Murillas, R., Navarro, M., Page, A., Suárez-Cabrera, C., Alameda, J. P., Bravo, A., Casanova, M., & Ramírez, Á. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/193803 · Cited by 5
Genetics in non-genetic model systems
Lois, C., & Groves, J. O. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.11.002 · Cited by 4
Genetic mouse models to investigate cell cycle regulation
Li, W., Kotoshiba, S., & Kaldis, P. (2009) · Transgenic Research · doi:10.1007/s11248-009-9276-x · Cited by 4
“The endogenous expression of the tumor suppressor gene Trp53, for example, was reversibly controlled using tet-regulated shRNA production (Dickins et al. 2007).”
BackgroundTargeted Approaches to Drug Development
Stegmaier, K., & Sellers, W. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00004-2 · Cited by 4
Recent Advances and Applications of Transgenic Animal Technology
Miao, X. (2012) · InTech eBooks · doi:10.5772/38040 · Cited by 6
“Dickins et al. (2007) combined the TRE with the RNAi sequence, and obtained transgenic mice having the hybrid gene.”
BackgroundNew advances in animal transgenic technology
Sun, Z., Miao, X., & Rui-Liang, Z. H. U. (2010) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2010.00539 · Cited by 3
“原始生殖细胞(Primordial germ cells, PGCs)是 指能够发育成为精子或卵子的祖先细胞, 来源于胚 胎生殖嵴, 与来源于囊胚内细胞团(Inner cell mass) 的胚胎干细胞同属全胚层多能干细胞 (Pluripotent stem cells)。原始生殖细胞可以定居在受体性腺, 并 能够在受体胚胎性腺迁移、增殖。又由于各个时期 的原始生殖细胞都可以作为转基因的受体细胞 [6], 故以其作为载体进行转基因研究较为简便、高效 , 并逐渐引起关注。 Natio等[7]从早期鸡胚血液分离得到了PGCs, 利 用脂质体法导入LacZ基因, 然后注入受体胚, 53 只 鸡胚发育到第 3 d且在生殖嵴表达了LacZ基…”
BackgroundInfluentialŞentürk, Ş., Shirole, N. H., Nowak, D. D., Corbo, V., Vaughan, A., Tuveson, D. A., Trotman, L. C., Kepecs, Á., Stegmeier, F. P., & Sordella, R. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/023366 · Cited by 3
“Hence, we sought to improve upon existing CRISPR/Cas9 techniques to generate a system that (1) would provide potent, robust and temporally controlled gene editing, (2) be applicable to a broad spectrum of cell types and tissues, (3) facilitate high throughput manipulation and (4) be tractable.”
BackgroundMethodDylla, S. J., Park, I., & Gurney, A. L. (2009) · Wiley eBooks · doi:10.1002/9780470454923.ch8 · Cited by 3
The application of experimental models for the drug discovery for digestive tumors
Zheng, L., Shuai, W., Liu, Y., Deng, Y., Bao, J., Hu, X., & Wang, G. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02558-6 · Cited by 4
“In parallel, in vivo RNA interference [426, 427] and viral vector–mediated somatic gene transfer using adenoviral, retroviral, or lentiviral vectors [428]offer complementary approaches for rapidly interrogating gene function and reconstructing somatic cancer-driving events.”
Organic small hairpin RNAs (OshR): A do-it-yourself platform for transgene-based gene silencing
Zeng, M., Kuzirian, M. S., Harper, L., Paradis, S., Nakayama, T., & Lau, N. C. (2013) · Methods · doi:10.1016/j.ymeth.2013.05.007 · Cited by 2
Mouse genetics in drug target discovery and validation: no simple answers to complex problems
Russ, A., & Grosse, J. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.10.1379 · Cited by 2
“, [5-10] ), and this paper focuses on some crucial conceptual issues of preclinical research.”
BackgroundAn RNAi-Based Approach to Down-Regulate a Gene Family In Vivo
Kim, J.-H., Badaloni, A., Willert, T., Zimber‐Strobl, U., Kühn, R., Wurst, W., & Kieslinger, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080312 · Cited by 2
“using the tet-transactivator to down-regulate p53 [52].”
RUSH and CRUSH: A rapid and conditional RNA interference method in mice
Brown, J. R., Zetsche, B., & Jackson‐Grusby, L. (2013) · genesis · doi:10.1002/dvg.22718 · Cited by 2
Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas
Daniel, A. R., Su, C., Williams, N. T., Li, Z., Huang, J., Lopez, O. M., Luo, L., Ma, Y., Campos, L. D. S., Selitsky, S. R., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0104 · Cited by 2
Multiomics approaches in cancer
Hameed, H., Faheem, S., Zaman, M., Khan, M. A., Ghumman, S. A., Sarwar, H. S., & Mahmood, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23971-7.00003-1 · Cited by 2
Development of a KDM6b shRNA conditional knock down mouse modelPreprint
Prier, J. E., Blewitt, M. E., Dickins, R. A., & Turner, S. T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/605618 · Cited by 1
“Generation of shRNA transgenic mice Effective shRNA sequences identified using the LMP-EBFP2 vector were excised with XhoI/EcoRI and cloned into a variant of the pCol-TGM vector (24), linking the shRNA to expression of green fluorescent protein (GFP) under control of the TRE3G promoter.”
BackgroundInfluentialSelf-citationBowman, R. L., Dunbar, A. J., Mishra, T., Xiao, W., Waarts, M. R., Fernández-Maestre, I., Eisman, S. E., Cai, L., Cai, S. F., Vela, P. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.18.492524 · Cited by 2
Wang, S., Wang, T., Wang, T., & Jia, L. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0137 · Cited by 1
“Of note is the generation of a Tet-regulated reproducible gene knockdown system in which Tet initiates the expression of a natural microRNA (miRNA) precursor and the subsequent miRNA splicing releases the embedded shRNA targeted to an individual gene (Dickins et al., 2007; Premsrirut et al., 2011).”
BackgroundRNA Interference Pathways and Therapeutic Exploitation
Bramsen, J. B., & Hansen, T. B. (2012) · Advances in delivery science and technology · doi:10.1007/978-1-4614-4744-3_1 · Cited by 2
Interference RNA for In vivo Knock-Down of Gene Expression or Genome-Wide Screening Using shRNA
Petit, S., & Thiam, K. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-389-3_14 · Cited by 1
Modeling osteosarcoma: in vitro and in vivo approaches
Walkley, C. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00017-0 · Cited by 3
Alternative Animal Models in Cancer Research
Meenu, M. S., Soumya, V. S., Mathew, J. M., & Panicker, S. P. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_55-1 · Cited by 1
Generation of Mouse Mutants by Genotype-Driven Mutagenesis
Rülicke, T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382008-2.00005-2 · Cited by 1
Strategies to Study the Functions of Pseudogenes in Mouse Models of Cancer
Bok, I., & Karreth, F. A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1503-4_18 · Cited by 2
MicroRNAs Regulating Autophagy in Neurodegeneration
Lai, Q., Kovzel, N., Konovalov, R., & Vinnikov, I. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-2830-6_11 · Cited by 1
Alternative Animal Models in Cancer Research
Meenu, M. S., Soumya, V. S., Mathew, J. M., & Panicker, S. P. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_55 · Cited by 1
Comparing the silencing efficacy of dicer-independent and dependent shRNAs
Nhlabatsi, N. (2015) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1
Jaako, P. (2012) · Lund University Publications (Lund University)
Defining Regulators of Human Hematopoietic Stem Cells
Karlsson, C. (2013) · Lund University Publications (Lund University)
Rusk, N. (2007) · Nature Methods · doi:10.1038/nmeth0807-610
“Lowe wanted to go beyond what he calls a chimeric setting, where cells are manipulated in vitro and then put back in the mouse, to a system in which the mouse expresses an shRNA that is stably integrated into its genome and can be induced to target an endogenous gene (Dickins et al., 2007).”
BackgroundThe Application of Transgenic Animals in MicroRNA Research
Ma, N., & Gao, X. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2009.00091
Ito, M. (2012) · Open Journal of Genetics · doi:10.4236/ojgen.2012.21008
“For transgenic RNAi in mice, one-cell embryos [16-29] or embryonic stem (ES) cells [30-37] have been used as the target (Table 1).”
BackgroundMethodInfluentialAdvances in the development of animal gene transfer
Zhendan, S., Li, W., Zhang, Y., & Chen, X. (2008) · Chinese Journal of Agricultural Biotechnology · doi:10.1017/s1479236208002179
Barichievy, S. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Characterization of Sirt2 using conditional RNAi in mice
Reiss, M. (2011) · Kölner Universitäts PublikationsServer (Universität zu Köln)
A Comprehensive Overview of Mouse Models in Oncology
Vats, D. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527695881.ch6
Evaluation of an Infertile Transgenic Male Animal
Eddy, E. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01104-0
Evaluation of an Infertile Transgenic Male Animal☆
Eddy, E. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02136-x
Cellular Senescence Limits the Extent of Fibrosis Following Liver Damage
Krizhanovsky, V. (2013) · Springer eBooks · doi:10.1007/978-94-007-5958-9_25
Self-citation
Metadata
- Authors
- Dickins, R. A., McJunkin, K., Hernando, E., Premsrirut, P. K., Krizhanovsky, V., Burgess, D. J., Kim, S. Y., Cordon-Cardo, C., Zender, L., Hannon, G. J., & Lowe, S. W.
- Affiliations
- Howard Hughes Medical Institute (US)
- Cold Spring Harbor Laboratory (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Lowe, Scott W
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-06-17
- Volume
- 39
- Issue
- 7
- Pages
- 914-921
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC4595852
- OpenAlex
- W2169151715
- Cited by
- 174
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 8 · 2016: 6 · 2015: 12 · 2014: 17 · 2013: 19 · 2012: 14
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- National Cancer Institute (P01CA087497, P01CA013106, P30CA008748)
- National Institute of General Medical Sciences (T32GM008444)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- RNA interference, shRNA, microRNA, Trp53, tissue-specific gene regulation, lymphoma, tumor regression, transgenic mice, endogenous gene expression
- MeSH terms
- Animals, Mice, Transgenic, Organ Specificity, Promoter Regions, Genetic, Tetracycline, Drug Delivery Systems, RNA Interference, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.